Robert Ang, M.B.B.S
2023
In 2023, Robert Ang, M.B.B.S earned a total compensation of $2.7M as President and Chief Executive Officer at Vor Biopharma, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $316,531 |
|---|---|
| Option Awards | $1,032,575 |
| Salary | $605,800 |
| Stock Awards | $714,563 |
| Other | $21,575 |
| Total | $2,691,044 |
MBBS received $1M in option awards, accounting for 38% of the total pay in 2023.
MBBS also received $316.5K in non-equity incentive plan, $605.8K in salary, $714.6K in stock awards and $21.6K in other compensation.
Rankings
In 2023, Robert Ang, M.B.B.S' compensation ranked 353rd out of 2,983 executives tracked by ExecPay. In other words, MBBS earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 353 out of 2,983 | 88th |
Division Manufacturing | 201 out of 1,637 | 88th |
Major group Chemicals And Allied Products | 138 out of 906 | 85th |
Industry group Drugs | 135 out of 869 | 85th |
Industry Biological Products, Except Diagnostic Substances | 48 out of 211 | 77th |
Source: SEC filing on April 9, 2024.
MBBS' colleagues
We found two more compensation records of executives who worked with Robert Ang, M.B.B.S at Vor Biopharma in 2023.